EFPIA - NEWSLETTER

EFPIA Newsletter 17 March 2022

News

05 October 2022 Pharmaceutical industry response to the war in Ukraine

Supporting people affected by the war

16 March 2022 WTO proposal to waive COVID vaccine IP rights puts pandemic response at risk

Since the onset of the COVID-19, our only route to address the devastating human and economic cost of the pandemic was...

Blogs

14 March 2022 Unlocking New Insights to Improve the Health of Patients

With better data we can make more informed decisions and choices.

14 March 2022 Digital Health and Health Data Sharing – are patients involved in innovation?

Moving forward together towards better digital healthcare and better patient involvement.

Videos

Intellectual Property is part of the solution to get the world vaccinated against COVID-19

Intellectual property is the key driver of medical innovation.

Intellectual Property - the formula to a healthy Europe

Intellectual Property has the power to bring about vital medical innovation. It can create healthy populations. It can support people’s lives and their livelihoods.

Events

29 MAR 2022

DIA Europe 2022 Hybrid conference (virtual - Brussels)

Advancing Health Priorities

Learn more →

27 JUN 2022

11th European Conference on Rare Diseases & Orphan Products Virtual event

Putting rare diseases policy into action.

Learn more →

What we are reading

Equitable access to innovative COVID-19 vaccines in Africa should focus on healthcare system... 23 February 2022 (Vaccines Europe)

HAS-PFUE Symposium "Together for HTA in Europe" 07 March 2022 (HTA)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶